Successful treatment of life-threatening generalized infantile myofibromatosis using low-dose chemotherapy

Journal of Pediatric Hematology/Oncology

Volumn 25, Issue 9, 2003, Pages 750-754

  Gandhi, Minal M ^a   Nathan, Paul C ^b   Weitzman, Sheila ^b   Levitt, Gill A ^a  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Infantile myofibromatosis; Intensive care; Low dose chemotherapy

Indexed keywords

DACTINOMYCIN; METHOTREXATE; METHYLPREDNISOLONE; PHOSPHONIC ACID DERIVATIVE; PREDNISOLONE; VINBLASTINE; VINCRISTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CLINICAL FEATURE; CLINICAL PROTOCOL; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HUMAN; HUMAN TISSUE; INFANT MORTALITY; INTENSIVE CARE; LEIOMYOMA; LETHALITY; LOW DRUG DOSE; MALE; NEWBORN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; TREATMENT OUTCOME; TREATMENT PLANNING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DACTINOMYCIN; FEMALE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE; MALE; METHOTREXATE; MUSCLE NEOPLASMS; MYOFIBROMATOSIS; OSTEOLYSIS; PREDNISOLONE; REMISSION INDUCTION; RESPIRATION, ARTIFICIAL; SKIN NEOPLASMS; SOFT TISSUE NEOPLASMS; VINBLASTINE; VINCRISTINE;

EID: 0041733646     PISSN: 10774114     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200309000-00016     Document Type: Article

References (20)

1. Wiswell TE, Davis J, Cunningham BE, et al. Infantile myofibromatosis: the most common fibrous tumour of infancy. J Pediatr Surg. 1988;23:315-318.
2. Chung EB, Enzinger FM. Infantile myofibromatosis. Cancer 1981;48:1807-1818.
3. Raney B, Evans A, Granowetter L, Schaufer L. Nonsurgical management of children with recurrent or unresectable fibromatosis. Pediatrics. 1987;79:394-398.
4. Wallace WH, Blacklay A, Eiser C, et al. Developing strategies for the long term follow up of survivors of childhood cancer. Br Med J. 2001;323:271-274.
5. Zeller B, Storm-Mathison I, Smevik B, et al. Cure of infantile myofibromatosis with severe respiratory complications without antitumour therapy. Eur J Pediatr. 1997;156:841-844.
6. Hatzidaki E, Korakaki E, Voloudaki A, et al. Infantile myofibromatosis with visceral involvement and complete spontaneous regression. J Dermatol. 2001;28:379-382.
7. Nadel EM. Histopathology of oestrogen induced tumour in guinea pig. J Nat Cancer. 1950;10:1043-1065.
8. Coffin CM, Dehner LP. Fibroblastic-myofibroblastic tumours in children and adolescents: a clinicopathologic study of 108 examples in 103 patients. Pediatr Pathol. 1991;11:569-588. Review.
9. Savasan S, Fulgenzi LA, Rabah R, et al. Generalised infantile myofibromatosis in a patient with Turners syndrome: a trial of interferon alpha. J Pediatr. 1998;133:694-696.
10. Barlow CF, Priebe CJ, Mulliken JB, et al. Spastic diplegia as a complication of interferon alpha-2a treatment of haemangiomas of infancy. J Pediatr. 1998;132:527-530.
11. Coffin CM, Neilson KA, Ingels S, et al. Congenital generalised myofibromatosis: a disseminated angiocentric myofibromatosis. Pediatr Pathol Lab Med. 1995;15:571-587.
12. Day M, Edwards AO, Weinberg A, et al. Successful therapy of a patient with infantile generalised myofibromatosis. Med Pedatr Oncol. 2002;38:371-373.
13. Michel M, Ninane J, Claus D, et al. Major malformation in a case of infantile myofibromatosis. Eur J Pediatr. 1990;149:251-252.
14. Dimson OG, Drolet BA, Southern JF, et al. Congenital generalised myofibromatosis in a neonate. Arch Derm. 2000;136:597-600.
15. Pilz T, Pilgrim TB, Bisogno G, et al. [Chemotherapy in fibromatoses of childhood and adolescence: results from the Cooperative Soft Tissue Sarcoma Study (CWS) and the Italian Cooperative Study Group (ICG-AIEOP)]. Klin Padiatr. 1999;211 291-295.
16. Skapek SX, Hawk BJ, Hoffer FA, et al. Combination chemotherapy using vinblastine and methotrexate for the treatment of aggressive desmoid tumor in children. J Clin Oncol. 1998;16:3021-3027.
17. Weiss AJ, Lackman RD. Low dose chemotherapy of desmoid tumours. Cancer. 1989;64:1192-1194.
18. Azzarelli A, Gronchi A, Bertulli R, et al. Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive myofibromatosis. Cancer. 2001;92:1259-1264.
19. Klement G, Baruchel S, Rak J, et al. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. J Clin Invest. 2000;105:R15-24.
20. Munday GR. Bisphosphonates and tumour burden. J Clin Oncol. 2002;20:3191-3192.